In an independent study, Goel et al. (2017) showed that blocking CDK4/6 activity promotes cancer cell expression of endogenous retroviral elements, leading to enhanced tumor antigen presentation, demonstrating a different mechanism for T cell response. This evidence concerns the gene CDK4 and cancer.